• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD. GELWEAVE; GELWEAVE STRAIGHT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD. GELWEAVE; GELWEAVE STRAIGHT Back to Search Results
Model Number 733008
Device Problem Fluid/Blood Leak (1250)
Patient Problem Insufficient Information (4580)
Event Date 05/03/2022
Event Type  malfunction  
Event Description
Event was reported as follows: graft soaked in normal saline for 3 mins prior to removal and used for femoral artery anastomosis for cardiopulmonary bypass cannulation.Blood constantly leaking through permeable gelweave graft.The patient was profusely bleeding out of the femoral artery for the duration of the case.The result was haemolysis, constant blood loss and interruption to the surgical procedure.Patient was undergoing coronary bypass and aortic valve replacement.Estimated blood loss >250ml.
 
Manufacturer Narrative
(b)(4).Type of investigation: historical data analysis - a five-year review of similar reported events of graft leakage relating to gelweave branded grafts was completed, an occurrence rate of (b)(4) was confirmed.No similar events have been reported from the remainder of the batch (10 grafts manufactured in total).Trend analysis - no negative trend was identified.Communication/interviews - further information / biopsy results have been.Requested analysis if production records - quality, manufacturing and physical test records of the base material were retrieved and eviewed and show that the batch was manufactured to design specification and all tests met acceptance criteria.Specific emphasis was directed toward the porosity test results which indicate that the units passed - highest -03ml/min - lowest 01ml/min - max permitted 26ml/min.Investigation findings: results pending completion of the investigation.
 
Manufacturer Narrative
Type of investigation: 10 - testing of actual device/suspected device.4116 - incomplete device returned.2 sections of the graft returned.First section measured to 70mm and second section measured to 90mm in length.Full lengtht of the graft supplied to the customer was 300mm.Textile analysis did not identify any damage to the graft sections returned neither structurally nor cosmetically.The sample was consistent with an 8mm gelweave graft.Permeability test of the base fabric (2 samples tested) was within specification (=<515ml/min) with following results 132ml/min and 148lm/min.Investigation finding: 213 - no device problem found.Inspection and evaluation of the physical properties of the graft did not identify any holes, tears or cuts in the structure of the graft that could have contributed to the reported graft leakage.Investigation conclusion: 67 - no problem detected.4315 - cause not established.As no issues were identified during returned graft section evaluation and manufacturing records review, the root cause of the observed leakage could not be determined.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.Vascutek ltd considers this case closed.
 
Event Description
Event was reported as follows: graft soaked in normal saline for 3 mins prior to removal and used for femoral artery anastomosis for cardiopulmonary bypass cannulation.Blood constantly leaking through permeable gelweave graft.The patient was profusely bleeding out of the femoral artery for the duration of the case.The result was haemolysis, constant blood loss and interruption to the surgical procedure.Patient was undergoing coronary bypass and aortic valve replacement.Estimated blood loss >250ml.This report will provide returned sample evaluation information related to the initial report 9612515-2022-00007.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE
Type of Device
GELWEAVE STRAIGHT
Manufacturer (Section D)
VASCUTEK LTD.
newmains avenue
inchinnan business park
renfrewshire PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD.
newmains avenue
inchinnan business park
renfrewshire PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
renfrewshire PA4 9-RR
UK   PA4 9RR
MDR Report Key14673661
MDR Text Key303240086
Report Number9612515-2022-00007
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881105130
UDI-Public05037881105130
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K955230
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number733008
Device Catalogue Number733008-G
Device Lot Number221111016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/26/2022
Initial Date FDA Received06/13/2022
Supplement Dates Manufacturer Received05/26/2022
Supplement Dates FDA Received08/23/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-